Schlieren (Zürich), Switzerland, December 2, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, today announced that the first patient has been enrolled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback